The estimated Net Worth of Kurt Azarbarzin is at least $767 Thousand dollars as of 8 November 2019. Mr. Azarbarzin owns over 86,121 units of TELA Bio stock worth over $688,533 and over the last 5 years he sold TELA stock worth over $0. In addition, he makes $78,720 as Independent Director at TELA Bio.
kurt has made over 1 trades of the TELA Bio stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 86,121 units of TELA stock worth $1,119,573 on 8 November 2019.
The largest trade he's ever made was buying 86,121 units of TELA Bio stock on 8 November 2019 worth over $1,119,573. On average, kurt trades about 14,354 units every 0 days since 2019. As of 8 November 2019 he still owns at least 260,808 units of TELA Bio stock.
You can see the complete history of Mr. Azarbarzin stock trades at the bottom of the page.
kurt Azarbarzin serves as Independent Director of the Company. Kurt Azarbarzin has been a member of our Board since November 2018. Mr. Azarbarzin has served as Chief Executive Officer and a member of the board of directors of Verb Surgical Inc., a robotic surgery company, since July 2019. Mr. Azarbarzin previously served as Chief Technology Officer for CONMED Corporation, a global, publicly-traded medical device company dedicated to helping customers improve patient outcomes, from 2016 to July 2019. Mr. Azarbarzin is the former Founder of SurgiQuest, Inc., a medical device company focused on advancing minimally invasive surgery, and served as its Chief Executive Officer from 2005 until June 2016. Mr. Azarbarzin is a member of the executive board at Center for Biomedical Innovation and Technology at Yale University. Mr. Azarbarzin previously held leadership roles in Research and Development at U.S. Surgical & Tyco Healthcare. He earned a Bachelor of Science from the University of Bridgeport and completed advanced graduate studies in mechanical design at Bridgeport Engineering Institute and manufacturing engineering at Bradley University.
As the Independent Director of TELA Bio, the total compensation of kurt Azarbarzin at TELA Bio is $78,720. There are 5 executives at TELA Bio getting paid more, with Antony Koblish having the highest compensation of $2,399,600.
kurt Azarbarzin is 57, he's been the Independent Director of TELA Bio since 2020. There are 4 older and 11 younger executives at TELA Bio. The oldest executive at TELA Bio, Inc. is Maarten Persenaire, 63, who is the Co-Founder, Chief Medical Officer.
Kurt's mailing address filed with the SEC is C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355.
Over the last 5 years, insiders at TELA Bio have traded over $4,222,376 worth of TELA Bio stock and bought 4,343,227 units worth $46,898,981 . The most active insiders traders include Management Inc. Opaleye, Investments, Lpwong Roderic..., and Advisors Llc Orbi Med Capit.... On average, TELA Bio executives and independent directors trade stock every 18 days with the average trade being worth of $139,070. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 28 June 2024, trading 428,300 units of TELA stock currently worth $2,021,576.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio executives and other stock owners filed with the SEC include: